Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 
ORIGINAL ARTICLE
Ahead of print publication  

Analysis of factors affecting initial cyclosporine level and its impact on post transplant outcomes in acute leukemia


1 Department of Medical Oncology, Bone Marrow Transplant Unit, Maharashtra, India
2 Biostatistics, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Mumbai, Maharashtra, India

Correspondence Address:
Navin Khattry,
Department of Medical Oncology, Bone Marrow Transplant Unit, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Mumbai - 410 210, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

 > Abstract 

Background: Trough cyclosporine (CsA) blood level can influence incidence of graft-versus-host disease (GVHD) and relapse in patients with acute leukemia undergoing allogeneic hematopoietic stem cell transplant (HSCT). We sought to determine factors affecting initial trough CsA level (CsA-1) and its impact on transplant outcome in acute leukemia.
Materials and Methods: Seventy-seven patients underwent HSCT for acute leukemia between January 2008 and March 2013 and were included. GVHD prophylaxis included CsA + methotrexate (MTX) in 53 patients and CsA + mycophenolate mofetil (MMF) in 24 patients. CsA-1 was measured on day 3-5 of starting CsA and subsequent dose was modified to achieve therapeutic level of 150-200 ng/mL. According to CsA-1, patients were divided into three groups - 27 in Group A (dose escalated), 13 in Group B (dose de-escalated), and 37 in Group C (same dose continued).
Results: On univariate analysis, cyclophosphamide with total-body irradiation (TBI) based conditioning regimen and lower body mass index (BMI) were associated with lower CsA-1, while use of fludarabine and higher BMI were associated with higher CsA-1. On multivariate analysis, only fludarabine use and BMI affected CsA-1. Incidence of acute and chronic GVHD (aGVHD and cGVHD), transplant-related mortality, relapse incidence, and relapse-free and overall survival (OS) were similar in the three groups.
Conclusion: While fludarabine use in conditioning regimen and higher BMI leads to higher CsA-1, transplant outcomes are not affected by CsA-1.

Keywords: Acute leukemia, cyclosporine, graft-versus-host disease, hematopoietic stem cell transplantation



How to cite this URL:
Gupta A, Punatar S, Gawande J, Mathew L, Kannan S, Khattry N. Analysis of factors affecting initial cyclosporine level and its impact on post transplant outcomes in acute leukemia. J Can Res Ther [Epub ahead of print] [cited 2017 Jul 24]. Available from: http://www.cancerjournal.net/preprintarticle.asp?id=157338

.




 

 
Top
 
 
  Search
 
     Search Pubmed for
 
    -  Gupta A
    -  Punatar S
    -  Gawande J
    -  Mathew L
    -  Kannan S
    -  Khattry N
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  >Abstract
  In this article

 Article Access Statistics
    Viewed963    
    PDF Downloaded35    

Recommend this journal